iBio, Inc. Contracts & Agreements

Form of Placement Agency Agreement (Filed With SEC on November 30, 2023)

Form of Series C Common Warrant (Filed With SEC on November 30, 2023)

Form of Series D Common Warrant (Filed With SEC on November 30, 2023)

Form of Securities Purchase Agreement to be entered into in this Offering (Filed With SEC on November 30, 2023)

iBio, Inc. 2023 Omnibus Incentive Plan (Filed With SEC on November 28, 2023)

Seventh Amendment to Credit Agreement dated October 4, 2023 between iBio CDMO LLC and Woodforest National Bank and Fifth Amendment to the Guaranty dated October 4, 2023 between... (Filed With SEC on October 10, 2023)

Purchase and Sale Agreement, dated September 15, 2023, by and between iBio CDMO LLC and Majestic Realty Co (Filed With SEC on September 21, 2023)

Sixth Amendment, dated September 18, 2023, to the Credit Agreement by and between iBio CDMO LLC and Woodforest National Bank (Filed With SEC on September 21, 2023)

Purchase Agreement, dated as of August 4 2023, by and between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2023)

Registration Rights Agreement, dated as of August4, 2023, by and between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2023)

Exhibit Description (Filed With SEC on March 30, 2023)

Third Amendment to Credit Agreement dated February 21, 2023 between iBio CDMO LLC and Woodforest National Bank and Third Amended Guaranty of iBio, Inc (Filed With SEC on February 21, 2023)

Second Amendment to Credit Agreement dated February 9, 2023 by and between iBio, Inc. and Woodforest National Bank (Filed With SEC on February 14, 2023)

Special Incentive Bonus Agreement dated January 26, 2023 by and between iBio, Inc. and Martin Brenner (Filed With SEC on February 14, 2023)

Special Incentive Bonus Agreement dated January 26, 2023 by and between iBio, Inc. and Felipe Duran (Filed With SEC on February 14, 2023)

Offer Letter by and between iBio, Inc. and Felipe Duran dated January 23, 2023 (Filed With SEC on January 25, 2023)

Underwriting Agreement, dated December 6, 2022, by and between iBio, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 8, 2022)

Form of Pre-Funded Warrant (Filed With SEC on December 8, 2022)

Form of Series A Warrants (Filed With SEC on December 8, 2022)

Form of Series B Warrants (Filed With SEC on December 8, 2022)

Form of Representatives Warrants (Filed With SEC on December 8, 2022)

Separation Agreement and General Release, dated December 1, 2022, by and between iBio, Inc. and Thomas Isett (Filed With SEC on December 7, 2022)

Separation Agreement and General Release, dated December 1, 2022, by and between iBio, Inc. and Thomas Isett (Filed With SEC on December 2, 2022)

Termination Agreement and Release dated September 19, 2022 by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on November 14, 2022)

Lease dated September 10, 2021 by and between iBio, Inc., and San Diego Inspire 4, LLC (Filed With SEC on November 14, 2022)

Restricted Stock Unit Award Agreement dated November 10, 2022 by and between iBio, Inc. and Thomas Isett (Filed With SEC on November 14, 2022)

First Amendment to Credit Agreement entered into as of October 11, 2022 by and between iBio CDMO LLC with Woodforest National Ban (Filed With SEC on October 11, 2022)

Asset Purchase Agreement, dated September 16, 2022, by and between iBio, Inc. and Rubryc Therapeutics, Inc (Filed With SEC on September 21, 2022)

Third Amendment to Exclusive License Agreement, dated February 3, 2022, by and between University of Pittsburgh and iBio, Inc (Filed With SEC on May 12, 2022)

Form of Stock Purchase Agreement (Filed With SEC on May 12, 2022)

Form of Irrevocable Proxy For Voting Control (Filed With SEC on May 12, 2022)

Consulting Agreement with Randy J. Maddux (Filed With SEC on May 2, 2022)

Term Note of iBio CDMO LLC (Filed With SEC on November 4, 2021)

iBio, Inc. Warrant (Filed With SEC on November 4, 2021)

Purchase and Sale Agreement, dated November 1, 2021, by and among College Station Investors LLC, Bryan Capital Investors LLC, iBio CDMO LLC and iBio, Inc (Filed With SEC on November 4, 2021)

Equity Purchase Agreement dated November 1, 2021 by and between Bryan Capital Investors LLC and iBio, Inc (Filed With SEC on November 4, 2021)

Credit Agreement, dated November 1, 2021 by and, between iBio CDMO LLC with Woodforest National Bank (Filed With SEC on November 4, 2021)

Guaranty Agreement, dated November 1, 2021, by iBio, Inc. for the benefit of Woodforest National Bank (Filed With SEC on November 4, 2021)

Leasehold Deed of Trust, Assignment of Leases and Rents, Security Agreement and UCC Financing Statement for Fixture Filing by iBio CDMO LLC as grantor to the trustee for the... (Filed With SEC on November 4, 2021)

Security Agreement, dated November 1, 2021by iBio CDMO LLC for the benefit of Woodforest National Bank (Filed With SEC on November 4, 2021)

Environmental Indemnity Agreement, dated November 1, 2021 by iBio CDMO LLC and iBio, Inc. in favor of Woodforest National Bank (Filed With SEC on November 4, 2021)

Description of Securities of iBio, Inc (Filed With SEC on September 28, 2021)

Employment Agreement dated January 18, 2021, by and between iBio, Inc. and Martin B. Brenner (Filed With SEC on September 28, 2021)

Confidential Settlement and Mutual Release with Fraunhofer USA, Inc. dated May 4, 2021 (Filed With SEC on September 28, 2021)

Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)

Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)

Stock Purchase Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)

Second Amended and Restated Investor Rights Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)

Second Amended and Restated Voting Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)

Second Amended and Restated Right of First Refusal and Co-Sale Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)

Director Offer Letter (Filed With SEC on August 26, 2021)

Director Offer Letter (Filed With SEC on June 9, 2021)

Employment Agreement, dated as of April 30, 2021, by and between iBio, Inc. and Thomas F. Isett (Filed With SEC on May 6, 2021)

Exclusive License Agreement between the Company and University of Pittsburgh dated January 14, 2014 (Filed With SEC on February 16, 2021)

First Amendment to Exclusive License Agreement between the Company and the University of Pittsburgh dated August 11, 2016 (Filed With SEC on February 16, 2021)

Second Amendment to Exclusive License Agreement between the Company and the University of Pittsburgh dated December 2, 2020 (Filed With SEC on February 16, 2021)

Employment Agreement dated February 15, 2021 by and between iBio, Inc. and Robert Lutz, Effective March 4, 2021 (Filed With SEC on February 16, 2021)

Underwriting Agreement, dated December 8, 2020, between iBio, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2020)

Employment Agreement dated October 30, 2020 by and between iBio, Inc. and Randy J. Maddux, effective December 1, 2020 (Filed With SEC on November 3, 2020)

Description of Securities of iBio, Inc (Filed With SEC on October 13, 2020)

Consulting Agreement by and between iBio, Inc. and TechCXO, LLC, dated July 8, 2020 (Filed With SEC on October 5, 2020)

Indemnification Agreement by and between iBio, Inc., John Delta and TechCXO, LLC dated July 13, 2020 (Filed With SEC on October 5, 2020)

Amendment No. 1 to Equity Distribution Agreement, dated July 29, 2020, by and between iBio, Inc. and UBS Securities LLC (Filed With SEC on July 29, 2020)

Transition Agreement, dated June 12, 2020, between Robert Kay and iBio, Inc (Filed With SEC on June 17, 2020)

Form of Stock Option Agreement (Filed With SEC on June 17, 2020)

Equity Distribution Agreement, dated June 17 2020, by and between iBio, Inc. and UBS Securities, LLC (Filed With SEC on June 17, 2020)

Purchase Agreement, dated as of May 13, 2020, between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2020)

Amended and Restated Executive Employment Agreement, dated as of April 21, 2020, between iBio, Inc. and Thomas F. Isett (Filed With SEC on April 27, 2020)

Registration Rights Agreement, dated March 19, 2020, between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)

Purchase Agreement, dated March 19, 2020, between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)

Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 19, 2020)

Employment Agreement, dated as of March 10, 2020, between iBio, Inc. and Thomas F. Isett (Filed With SEC on March 13, 2020)

Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)

Statement of Work 2, dated February 6, 2020, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)

Form of Amended and Restated Series A Warrant to Purchase Common Stock (Filed With SEC on February 21, 2020)

Form of Amended and Restated Series B Warrant to Purchase Common Stock (Filed With SEC on February 21, 2020)

Form of Promissory Note (Filed With SEC on February 21, 2020)

Warrant Exchange and Amendment Agreement, between the Company and certain Holders, dated February 20, 2020 (Filed With SEC on February 21, 2020)

Underwriting Agreement, dated October 25, 2019, by and between iBio, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on October 29, 2019)

Underwriting Agreement, dated October 25, 2019, by and between iBio, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on October 28, 2019)

Form of Series A Warrant to Purchase Common Stock (Filed With SEC on October 28, 2019)

Form of Series B Warrant to Purchase Common Stock (Filed With SEC on October 28, 2019)

Form of Leak-Out Agreement (Filed With SEC on October 28, 2019)

Form of Underwriting Agreement (Filed With SEC on October 24, 2019)

Form of Leak-Out Agreement (Filed With SEC on October 24, 2019)

Form of Underwriting Agreement (Filed With SEC on October 15, 2019)

Form of Series A Warrant to Purchase Common Stock (Filed With SEC on October 15, 2019)

Form of Series B Warrant to Purchase Common Stock (Filed With SEC on October 15, 2019)

2018 Omnibus Equity Incentive Plan, effective December 18, 2018 (Filed With SEC on August 26, 2019)

Form of Indemnification Agreement (Filed With SEC on April 1, 2019)

Amendment, dated June 26, 2018, to Share Purchase Agreement, dated January 13, 2016, between iBio, Inc. and Eastern Capital Limited, for the purchase of 6,500,000 shares of common... (Filed With SEC on June 27, 2018)

Underwriting Agreement, dated June 21, 2018, by and between iBio, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on June 22, 2018)

Form of Underwriting Agreement (Filed With SEC on June 21, 2018)

Amended and Restated Underwriting Agreement, dated November 30, 2017, by and between iBio, Inc. and Aegis Capital Corp (Filed With SEC on December 1, 2017)

Underwriting Agreement, dated November 29, 2017, by and between iBio, Inc. and Aegis Capital Corp (Filed With SEC on November 29, 2017)

PURCHASE AGREEMENT (Filed With SEC on July 24, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 24, 2017)

EXCHANGE AGREEMENT (Filed With SEC on February 24, 2017)

AMENDMENT NO. 1 TO Amendedand Restated Limited Liability Company Agreement Of iBioCMO LLC February 23, 2017 (Filed With SEC on February 24, 2017)

AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENT (Filed With SEC on March 2, 2016)

AMENDED AND RESTATED LIMITED LIABILITYCOMPANY AGREEMENT OF IBIO CMO LLC A Delaware Limited Liability Company Dated as of January 13,2016 (Filed With SEC on February 22, 2016)

License Agreement (Filed With SEC on February 22, 2016)

SUBLEASE AGREEMENT BETWEEN COLLEGE STATION INVESTORS LLC, Landlord, AND IBIO CMO LLC, Tenant Date: January 13, 2016 Property Address: 8800Health Science Center Parkway, Bryan,... (Filed With SEC on February 22, 2016)

SHARE PURCHASE AGREEMENT (Filed With SEC on January 14, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 15, 2015)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on May 15, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 26, 2014)

COMMON STOCKPURCHASE AGREEMENT (Filed With SEC on August 26, 2014)

ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission -- Doubleasterisks denote omissions -- EBY CONNER SMILLIE & BOURQUE, PLLC... (Filed With SEC on September 30, 2013)

IBIO, INC. 15,385,000 Units Each Unit Consisting of One Share of Common Stock and 0.75 of One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 10, 2012)

FORM OF COMMON STOCK PURCHASE WARRANT IBIO, INC. (Filed With SEC on January 10, 2012)